Pharmacological left ventricular reverse remodeling in elderly patients receiving optimal therapy for chronic heart failure

European Journal of Heart Failure

Volumn 7, Issue 6, 2005, Pages 1040-1048

  Cioffi, Giovanni ^a   Tarantini, Luigi ^b   De Feo, Stefania ^c   Pulignano, Giovanni ^d   Del Sindaco, Donatella ^e   Stefenelli, Carlo ^a   Opasich, Cristina ^c  

^a Villa Bianca Hospital   (Italy)

^b SAN MARTINO HOSPITAL   (Italy)

^c IRCCS   (Italy)

^d SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^e INRCA   (Italy)

Author keywords

Chronic heart failure; Dilated cardiomyopathy; Elderly population; Left ventricular reverse remodeling; Left ventricular systolic dysfunction

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL;

AGED; ARTERIAL PRESSURE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFECT; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; GEOMETRY; HEART FAILURE; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HEART VENTRICLE REMODELING; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; SYMPTOM;

ADRENERGIC BETA-ANTAGONISTS; AGE FACTORS; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CARDIOMYOPATHY, DILATED; CASE-CONTROL STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; GERIATRIC ASSESSMENT; HEART FUNCTION TESTS; HUMANS; LOGISTIC MODELS; MALE; MAXIMUM TOLERATED DOSE; PROBABILITY; PROSPECTIVE STUDIES; REFERENCE VALUES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 26644441214     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2004.11.003     Document Type: Article

References (35)

1. G.S. Francis, and C. Chu Post-infarction myocardial remodelling: why does it happen? Eur Heart J 16 Suppl. N 1995 31 36
2. W.F. Saavedra, R.S. Tunin, N. Paolocci, T. Mishima, G. Suzuki, and C.W. Emala Reverse remodeling and enhanced adrenergic reserve from passive external support in experimental dilated heart failure J Am Coll Cardiol 39 2002 2069 2076
3. G. Cioffi, and C. Stefenelli Reversibility of left ventricular dysfunction in elderly patients with dilated cardiomyopathy undergoing treatment with carvedilol. Report of a case Ital Heart J 2 2001 668 672
4. J.M. Arizon, M. Anguita, F. Torres, D. Gimenez, G. Bueno, and M. Concha Spontaneous remission in a patient with long-term idiopathic dilated myocardiopathy Rev Esp Cardiol 45 1992 354 356
5. J. Saini, M.W. Rich, and A.P. Lyss Reversibility of severe left ventricular dysfunction due to doxorubicin cardiotoxicity. Report of three cases Ann Intern Med 106 1987 814 816
6. K. Kawai, H. Takaoka, K. Hata, Y. Yokota, and M. Yokoyama Prevalence, predictors, and prognosis of reversal of maladaptive remodeling with intensive medical therapy in idiopathic dilated cardiomyopathy Am J Cardiol 84 1999 671 676
7. T.B. Levine, A.B. Levine, S.J. Keteyian, B. Narins, and M. Lesch Reverse remodeling in heart failure with intensification of vasodilator therapy Clin Cardiol 20 1997 697 702
8. M.A. Konstam, R.D. Patten, I. Thomas, T. Ramahi, K. La Bresh, and S. Goldman Effects of losartan and captopril on left ventricular volumes in elderly patients with heart failure: results of the ELITE ventricular function substudy Am Heart J 139 2000 1081 1087
9. R.N. Doughty, G.A. Whalley, G. Gamble, S. MacMahon, and N. Sharpe Left ventricular remodeling with carvedilol in patients with congestive heart failure due to ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group J Am Coll Cardiol 29 1997 1060 1066
10. R.S. Khattar, R. Senior, P. Soman, R. van der Does, and A. Lahiri Regression of left ventricular remodeling in chronic heart failure: comparative and combined effects of captopril and carvedilol Am Heart J 142 2001 704 713
11. C.M. Yu, E. Chau, J.E. Sanderson, K. Fan, M.O. Tang, and W.H. Fung Tissue Doppler echocardiographic evidence of reverse remodeling and improved synchronicity by simultaneously delaying regional contraction after biventricular pacing therapy in heart failure Circulation 105 2002 438 445
12. P. Giannuzzi, P.L. Temporelli, U. Corrà, L. Tavazzi for the ELVD-CHF Study Group Antiremodeling effect of long-term exercise training in patients with stable chronic heart failure. Results of the exercise in left ventricular dysfunction and chronic heart failure (ELVD-CHF) trial Circulation 108 2003 554 559
13. T.B. Levine, A.B. Levine, J. Bolenbaugh, and P.R. Green Reversal of heart failure remodeling with age Am J Geriatr Cardiol 11 2002 299 304
14. A. Palazzuoli, F. Bruni, L. Puccetti, M. Pastorelli, P. Angori, and A.L. Pasqui Effects of carvedilol on left ventricular remodeling and systolic function in elderly patients with heart failure Eur J Heart Fail 4 2002 765 770
15. M. Senni, C.M. Tribouilloy, R.J. Rodeheffer, S.J. Jacobsen, J.M. Evans, and K.R. Bailey Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991 Circulation 98 1998 2282 2289
16. M.E. Charlson, P. Pompei, K.L. Ales, and C.R. MacKenzie A new method of classifying prognostic comorbidity in longitudinal studies: development and validation J Chronic Dis 40 1987 373 383
17. G. Cioffi, C. Stefenelli, L. Tarantini, and C. Opasich Prevalence, predictors and prognostic implications of improvement in left ventricular systolic function and clinical status in patients >70 years of age with recently diagnosed systolic heart failure Am J Cardiol 92 2003 166 172
18. B. Greenberg, M.A. Quinones, C. Koilpillai, M. Limacher, D. Shindler, and C. Benedict Effects of long-term enalapril therapy on cardiac structure and function in patients with left ventricular dysfunction. Results of the SOLVD echocardiography substudy Circulation 91 1995 2573 2581
19. S.D. Solomon, M. St John Sutton, G.A. Lamas, T. Plappert, J.L. Rouleau, H. Skali Survival and Ventricular Enlargement (SAVE) Investigators Ventricular remodeling does not accompany the development of heart failure in diabetic patients after myocardial infarction Circulation 106 2002 1251 1255
20. N.B. Schiller, P.M. Shah, M. Crawford, A. DeMaria, R. Devereux, and H. Feigenbaum Recommendations for quantitation of the left ventricle by two-dimensional echocardiography J Am Soc Echocardiogr 2 1989 358 367
21. K. Miyatake, S. Izumi, M. Okamoto, N. Kinoshita, M. Asonuma, and H. Nakagawa Semiquantitative grading of severity of mitral regurgitation by real time two dimensional Doppler flow imaging technique J Am Coll Cardiol 7 1986 82 88
22. T.H. Lee, M.A. Hamilton, L.W. Stevenson, J.D. Moriguchi, G.C. Fonarow, and J.S. Child Impact of left ventricular cavity size on survival in advanced heart failure Am J Cardiol 72 1993 672 676
23. M.A. Konstam, M.W. Kronenberg, M.F. Rousseau, J.E. Udelson, J. Melin, and D. Stewart Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dilatation in patients with asymptomatic systolic dysfunction. SOLVD (Studies of Left Ventricular Dysfunction) Investigators Circulation 88 1993 277 283
24. C.M. Yu, W.H. Fung, H. Lin, Q. Zhang, J.E. Sanderson, and C.P. Lau Predictors of left ventricular reverse remodeling after cardiac resynchronization therapy for heart failure secondary to idiopathic dilated or ischemic cardiomyopathy Am J Cardiol 91 2003 684 688
25. I.S. Anand, V.G. Florea, S.D. Solomon, M.A. Konstam, and J.E. Udelson Non invasive assessment of left ventricular remodeling: concepts, techniques, and implications for clinical trials J Card Fail 8 2002 S452 S464
26. B.D. Lowes, E.A. Gill, W.T. Abraham, J.R. Larrain, A.D. Robertson, and M.R. Bristow Effects of carvedilol on left ventricular mass, chamber geometry, and mitral regurgitation in chronic heart failure Am J Cardiol 83 1999 1201 1205
27. S. Capomolla, O. Febo, M. Gnemmi, G. Riccardi, C. Opasich, and A. Caporotondi Beta-blockade therapy in chronic heart failure: diastolic function and mitral regurgitation improvement by carvedilol Am Heart J 139 2000 596 608
28. M. Metra, S. Nodari, G. Parrinello, R. Giubbini, C. Manca, and L. Dei Cas Marked improvement in left ventricular ejection fraction during long-term beta-blockade in patients with chronic heart failure: clinical correlates and prognostic significance Am Heart J 145 2003 292 299
29. A.P. Coletta, A.A. Louis, A.L. Clark, N. Nikitin, and J.G. Cleland European Society of Cardiology. Clinical trials update from the European Society of Cardiology: CARMEN, EARTH, OPTIMAAL, ACE, TEN-HMS, MAGIC, SOLVD-X and PATH-CHF II Eur J Heart Fail 4 2002 661 666
30. M. Cicoira, L. Zanolla, L. Latina, A. Rossi, G. Golia, and G. Brighetti Frequency, prognosis and predictors of improvement of systolic left ventricular function in patients with "classical" diagnosis of idiopathic dilated cardiomyopathy Eur Heart Fail J 3 2001 323 330
31. C. Opasich, C. Rapezzi, D. Lucci, M. Gorini, F. Pozzar, and E. Zanelli Italian network on congestive heart failure (IN-CHF) investigators. Precipitating factors and decision-making processes of short-term worsening heart failure despite "optimal" treatment (from the IN-CHF registry) Am J Cardiol 88 2001 382 387
32. B.D. Lowes, E.M. Gilbet, W.T. Abraham, W.A. Minobe, P. Larrabee, and D. Ferguson Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents N Engl J Med 346 2002 1357 1365
33. M. Fujimura, Y. Yasumura, Y. Ishida, S. Nakatani, K. Komamura, and M. Yamagishi Improvement in left ventricular function in response to carvedilol is accompanied by attenuation of neurohumoral activation in patients with dilated cardiomyopathy J Card Fail 6 2000 3 10
34. F. Romeo, D. Li, and J.L. Metha Carvedilol prevents epinephrine-induced apoptosis in human coronary artery endothelial cells: modulation of Fas/Fas ligand and caspase-3 pathway Cardiovasc Res 45 2000 788 794
35. C. Depre, J.L. Vanoverschelde, and H. Taegtmeyer Glucose for the heart Circulation 99 1999 578 588